Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Absci Corp (NQ: ABSI )

1.670 +0.040 (+2.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 383,617
Open 1.660
Bid (Size) 1.450 (40)
Ask (Size) 1.650 (2)
Prev. Close 1.630
Today's Range 1.570 - 1.690
52wk Range 1.111 - 3.630
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire

Performance

YTD
-26.11%
-26.11%
1 Month
+28.46%
+28.46%
3 Month
-6.70%
-6.70%
6 Month
-9.24%
-9.24%
1 Year
-33.20%
-33.20%

More News

Read More
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
From Almirall S.A.
Via Business Wire
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
From Absci Corporation
Via GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
From Absci Corporation
Via GlobeNewswire
Absci to Host R&D Day on October 4, 2023
From Absci Corporation
Via GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
The 3 Most Undervalued Penny Stocks to Buy Now: August 2023
Via InvestorPlace
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
From Absci Corporation
Via GlobeNewswire
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
From Absci Corporation
Via GlobeNewswire
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
From Absci Corporation
Via GlobeNewswire
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
From Absci Corporation
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Via Benzinga
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
From Absci Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.